PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

44,651 stories, page 613 of 745

Advanced search
🌍Researchdoi.orgTier 1 · Research record

Comparative risk of ventricular arrhythmia and sudden cardiac death among acetylcholinesterase inhibitors in dementia: A population‐based cohort study

CrossrefOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07682272: A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07681245: Label-free Femtosecond Laser Imaging Combined With the Fast Lung Artificial Intelligence Model for Rapid Intraoperative Diagnosis of Lung Surgical Specimens: A Multicentre, Prospective, Parallel-workflow, Non-inferiority Study.

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07680764: A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07680465: Prevalence of Pelvic Venous Congestion Syndrome in Female Patients With Lower Extremity Varicose Veins and Its Impact on Postoperative Quality of Life Improvement Following Radiofrequency Ablation: A Single-Center Prospective Cohort Study(PCSRFStudy)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07680439: Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07669545: Risk Stratification and Treatment Decisions in Infantile Hemangioma With Minimal or Arrested Growth

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07663539: Insights From Bereaved Parents and Oncologists

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07632638: Safety and Performance Evaluation of the RonovoTM Robotic Surgical Platform in Oncological Procedures

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07501754: Use of a Custom-Made Acrylic Palatal Stent to Minimize Donor Site Morbidity After Suture-Free Epithelialized Gingival Graft Harvesting: A Randomized Clinical Trial

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07270562: ORbital Atherectomy for Lesion Preparation in Patients With Chronic Limb-threatening ischEmia

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07221500: A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT07154745: A Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06859255: In-vitro Benchmarking of Currently Available Heart Valve Prostheses for Surgical and Percutaneous Treatment of Aortic Stenosis With Small Annulus, Followed by In-vivo Validation

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06692179: An Open-Label, Pilot Clinical Trial To Test The Safety And Feasibility Of A Suspension of Freeze-dried Microbiota In Patients Undergoing Colon Resection

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06489535: Retention and Re-Engagement in Treatment for Addiction Following Serious Injection Related Infections (RETAIN)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06464185: A Prospective Clinical Study of CD3-CD20 Bisspecific Antibody Based Therapy Combined With CD19-CAR T Cells in the Treatment of Relapsed Refractory B-cell Non-Hodgkin Lymphoma

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06323837: Mirtazapine for the Treatment of Methamphetamine Use in Opioid Use Disorder Patients Receiving Medication Assisted Treatment

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06170788: Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06101277: Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06066723: 19F MRI in Healthy Children and Children With Mild Cystic Fibrosis Lung Disease

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT06052254: Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05990075: An eHealth Intervention to Increase Depression Treatment Initiation and Adherence Among Veterans Referred for Mental Health Services

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05979311: A Study to Evaluate the Efficacy, Safety, and Tolerability of Using an Oral Once-daily 2 Drug Regimen Compared to an Oral Once-daily 3 Drug Regimen for the Treatment of Human Immunodeficiency Virus (HIV)-1 in Adults Who Have Not Previously Taken Antiretroviral Therapy

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05797870: Selective Internal Radiation Therapy and 188Re-SSS Lipiodol Treatment for Liver Cancer (Lip-Re2)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT05504720: Evaluating Pembrolizumab, Trastuzumab and FLOT as Perioperative Treatment of HER2-positive, Localized Esophagogastric Adenocarcinoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04864158: Prosthesis Versus Active Exercise Program in Patients With Rotator Cuff Arthropathy

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04821895: Oncogenetic Panel and Integrated Clinical Data Registry Study for Wild Type Gastrointestinal Stromal Tumor Patients

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04603001: Study of Oral LY3410738 in Patients With Advanced Hematologic Malignancies With IDH1 or IDH2 Mutations

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04427761: A Study of the Life Changes Experienced by Patients With Pancreatic Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT04264897: Antecedent Metabolic Health and Metformin Aging Study

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03603002: Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT03391973: Pembrolizumab in Patients With Poor-Prognosis Carcinoma of Unknown Primary Site (CUP)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02471170: Protocol to Permit the Acquisition of Circulating Tumor Material in Pancreatic Diseases

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT02225600: The Effect of Oxytocin Administration on Interpersonal Cooperation in Borderline Personality Disorder Patients and Healthy Adults

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01778569: The Psoriasis, Atherosclerosis, and Cardiometabolic Disease Initiative (PACI)

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source
🇺🇸Researchclinicaltrials.govTier 1 · Trial registry

NCT01325961: Medico-economic Evaluation of IMRT by Hi Art, RapidArc, VMAT Therapy in Prostate, Cervix and Anal Canal Cancers

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

World Pharmaceutical Grade Amino Acid Global - Market Analysis, Forecast, Size, Trends and Insights

IndexBoxOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AOB Pharma Taps Biorasi to Execute Phase 2b Acne Trial; Company Maintains Phase 3 AD Trial Timeline

The Dermatology DigestOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA scientists warn against expanded peptide access as Kennedy reshapes advisory panel

Medical XpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VIVAZEN® Commends the Drug Enforcement Administration’s Decision to Schedule Synthetic 7-Hydroxymitragynine (7-OH) and Three Related Drugs

Business WireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Draft for Comments || Guidelines on the Classification of Deficiencies Observed During Inspection of Drug Distributors, Drugstores, Hospital Pharmacies and Retail Outlet for Non-Prescription Drugs (RONPD)

fda.gov.phOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jetema signs Zydus deal to bring GLP-1 biosimilar to South Korea - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

KCMC drives Korea to build CMC muscle, cut China reliance, win drug approvals - CHOSUNBIZ

ChosunbizOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rentschler BioPharma hires Swiss biotech executive as next CEO

Worcester Business JournalOriginal source
🌍discoverynews.google.comTier 1 · Regulatory source

MAGNUM Brand products may be harmful due to hidden drug ingredients

fda.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Wall Street Thinks This High-Flying Biotech Stock Can Soar Another 57%

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Controversial drug at center of multibillion-dollar Amgen deal faces more questions after paper retracted

The Business JournalsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

LSD therapy biotech Definium fends off trade-secret lawsuit

ReutersOriginal source
🇺🇸Devicesir.idexx.comTier 1 · Company source

IDEXX Laboratories to Release 2026 Second Quarter Financial Results

IDEXX LaboratoriesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

HHS, FDA Commend DEA Action Against Dangerous Enhanced 7-OH Products

HHS.govOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

The Medicare GLP-1 Bridge | PharmExec

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Biotech's Resurgence: A Video Recap of BIO 2026

BioPharm InternationalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients

markets.businessinsider.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA approves Augmentin XR (amoxicillin-clavulanate potassium) under the Commissioner's National Priority Voucher pilot program, completing review in two months and expanding indications for community-acquired pneumonia and acute bacterial sinusitis i

Vera HealthOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Rezdiffra Reduces Cardiovascular, Liver-Related Risk Markers in MASH

Drug TopicsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

June's Top ETFs: Biotech & China Semiconductors Surge

ETF DatabaseOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA’s sunscreen rules leave Americans exposed

The Natchez DemocratOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Scientists Warn Against Expanded Peptide Access As Kennedy Reshapes Advisory Panel

U.S. News & World ReportOriginal source